RecruitingNot applicableNCT02958462
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Studying Autosomal dominant aplasia and myelodysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Mrinal S. Patnaik, MBBSMayo Clinic
- Intervention
- Biospecimen Collection(procedure)
- Enrollment
- 2000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2035
Study locations (3)
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Mayo Clinic in Florida, Jacksonville, Florida, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02958462 on ClinicalTrials.govOther trials for Autosomal dominant aplasia and myelodysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06090669Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 DeficiencyNational Cancer Institute (NCI)
- RECRUITINGNANCT04781790French National Registry of Bone Marrow FailuresAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT01905826Natural History Study of GATA2 Deficiency and Related DisordersNational Institute of Allergy and Infectious Diseases (NIAID)
See all trials for Autosomal dominant aplasia and myelodysplasia →